| Literature DB >> 29061240 |
Kashif Jafri1, Sarah L Patterson1, Cristina Lanata2.
Abstract
Neuropsychiatric systemic lupus erythematosus (NPSLE) encompasses a variety of phenomena. Manifestations are focal or diffuse, and correlate with disease mechanisms. Recent understanding of the contribution of blood-brain barrier dysfunction to the passage of circulating antineuronal antibodies into the brain parenchyma has shed light on pathogenesis. Correct attribution of neuropsychiatric manifestations to SLE remains a challenge, but validated attribution models will help. Diagnosis relies on characteristic clinical manifestations, SLE disease activity, antibody measurements, cerebrospinal fluid findings, specific neuroimaging findings, and exclusion of alternative etiologies. Current treatment encompasses the identification and management of the inciting event, symptomatic treatment, and anticoagulation or immunosuppression.Entities:
Keywords: Anti-neuronal antibody; Blood–brain barrier dysfunction; Neuropsychiatric lupus
Mesh:
Year: 2017 PMID: 29061240 DOI: 10.1016/j.rdc.2017.06.003
Source DB: PubMed Journal: Rheum Dis Clin North Am ISSN: 0889-857X Impact factor: 2.670